ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolutionShinsuke Oshima, Yasuyuki Higashi|Protein Engineering Design and Selection|2016Cited by 7